CpODA>95.0%(HPLC)25g

3,4-Dibromo-2-fluoroaniline, 1g

2-Amino-5-(2-methoxyphenylcarbamoyl)-4-methyl-thiophene-3-carboxylic acid methyl ester, 250mg

(2-Methyl-4-(trifluoromethyl)thiazol-5-yl)methanamine, 97.0%, 250mg

2-(3-Bromo-6-morpholin-4-yl-4-trifluoromethyl-pyridin-2-ylamino)-ethanol, 95.0%, 1g

4-Chloro-2-fluorocinnamic Acid>97.0%(GC)(T)5g

(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II), 98%, 5g

7-METHYL-1H-INDOLE-5-CARBOXYLIC ACID, 95.0%, 500mg

4-Cyano-4'-methylbiphenyl, 95.0%, 25g

3-Bromopyridine-2-carboximidamide;hydrochloride, 97%, 500mg

Recipiente de cristalización DURAN® sin pico, 900 ml, 140 mm, 1 Pieza

(4-Ethoxy-2,3,5,6-tetrafluorophenyl)boronic acid, 95.0%, 100mg

Filtres pour seringues Millex® Polytétrafluoroéthylène hydrophobe (PTFE), 0,45 µm, 4 mm, Millex®-FH, 100 pièce(s)